Invention Grant
- Patent Title: Method for removing anti-AAV antibodies from a blood-derived composition
-
Application No.: US16490181Application Date: 2018-03-01
-
Publication No.: US11376321B2Publication Date: 2022-07-05
- Inventor: Bérangére Bertin , Carole Masurier , Otto-Wilhelm Merten , Federico Mingozzi
- Applicant: GENETHON , INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) , SORBONNE UNIVERSITÉ , ASSOCIATION INSTITUT DE MYOLOGIE
- Applicant Address: FR Evry; FR Paris; FR Paris; FR Paris
- Assignee: GENETHON,INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE),SORBONNE UNIVERSITÉ,ASSOCIATION INSTITUT DE MYOLOGIE
- Current Assignee: GENETHON,INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE),SORBONNE UNIVERSITÉ,ASSOCIATION INSTITUT DE MYOLOGIE
- Current Assignee Address: FR Evry; FR Paris; FR Paris; FR Paris
- Agency: Saliwanchik, Lloyd & Eisenschenk
- Priority: EP17305228 20170302
- International Application: PCT/EP2018/055108 WO 20180301
- International Announcement: WO2018/158397 WO 20180907
- Main IPC: A61K39/235
- IPC: A61K39/235 ; A61M1/36 ; C07K16/06 ; C07K16/08 ; C12N7/00
Abstract:
The present invention relates to a method for removing undesired anti-AAV antibodies from a blood-derived composition.
Public/Granted literature
- US20200069790A1 METHOD FOR REMOVING ANTI-AAV ANTIBODIES FROM A BLOOD-DERIVED COMPOSITION Public/Granted day:2020-03-05
Information query
